Concentrix Corporation $CNXC Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. cut its holdings in Concentrix Corporation (NASDAQ:CNXC) by 2.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,057,012 shares of the company’s stock after selling 103,359 shares during the period. Vanguard Group Inc. owned 8.12% of Concentrix worth $233,381,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Geneos Wealth Management Inc. raised its position in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the period. Quent Capital LLC purchased a new stake in shares of Concentrix in the third quarter valued at about $29,000. True Wealth Design LLC lifted its position in Concentrix by 39.3% in the second quarter. True Wealth Design LLC now owns 1,163 shares of the company’s stock valued at $61,000 after purchasing an additional 328 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Concentrix by 23.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,818 shares of the company’s stock worth $96,000 after purchasing an additional 351 shares in the last quarter. Finally, Osaic Holdings Inc. raised its position in Concentrix by 13.4% during the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company’s stock worth $118,000 after acquiring an additional 263 shares during the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Concentrix Stock Performance

Shares of NASDAQ CNXC opened at $32.80 on Monday. Concentrix Corporation has a 12 month low of $29.35 and a 12 month high of $66.00. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.67. The company has a market cap of $2.01 billion, a P/E ratio of -1.57, a P/E/G ratio of 0.34 and a beta of 0.50. The business’s 50 day moving average is $38.61 and its two-hundred day moving average is $42.55.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The company had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period last year, the company posted $3.26 earnings per share. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, equities analysts expect that Concentrix Corporation will post 10.11 EPS for the current year.

Concentrix Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were issued a dividend of $0.36 per share. The ex-dividend date of this dividend was Friday, January 30th. This represents a $1.44 annualized dividend and a dividend yield of 4.4%. Concentrix’s payout ratio is -6.91%.

Analyst Ratings Changes

Several analysts have recently issued reports on CNXC shares. Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Robert W. Baird set a $52.00 target price on Concentrix in a research note on Wednesday, January 14th. Barrington Research reiterated an “outperform” rating and issued a $62.00 target price on shares of Concentrix in a research report on Monday, January 12th. Finally, Weiss Ratings cut Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Concentrix has an average rating of “Hold” and a consensus price target of $63.75.

Insider Transactions at Concentrix

In related news, CEO Christopher A. Caldwell bought 1,000 shares of the business’s stock in a transaction that occurred on Thursday, January 29th. The shares were bought at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. This represents a 0.28% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.90% of the stock is currently owned by insiders.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.